The company has announced an interesting bolt-on acquisition, which boosts its Life Sciences operations and continues the group’s progress in moving up the value-added ladder. The purchase of ITL for a total price of up to £22.0m is expected to be EPS-enhancing in its first full year. We raise our 2019 earnings forecast by 6% to 63.3p, prompting a 6% increase in our price target from 1520p to 1610p. We think that the acquisition is a good fit and addresses some key targeted areas
08 Aug 2018
Gooch & Housego - Acquisition lifts Life Sciences earnings
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Gooch & Housego - Acquisition lifts Life Sciences earnings
Gooch & Housego PLC (GHH:LON) | 546 -21.8 (-0.7%) | Mkt Cap: 140.8m
- Published:
08 Aug 2018 -
Author:
David Buxton -
Pages:
4
The company has announced an interesting bolt-on acquisition, which boosts its Life Sciences operations and continues the group’s progress in moving up the value-added ladder. The purchase of ITL for a total price of up to £22.0m is expected to be EPS-enhancing in its first full year. We raise our 2019 earnings forecast by 6% to 63.3p, prompting a 6% increase in our price target from 1520p to 1610p. We think that the acquisition is a good fit and addresses some key targeted areas